Myriad
Eurobio Scientific Acquires EndoPredict, Licenses Prolaris ex-US from Myriad Genetics
Myriad retained the rights to produce and sell EndoPredict in the US as part of its Precise Oncology Solutions platform.
Myriad Genetics, Personalis Cross-License MRD Technology
The companies inked an agreement to co-license their minimal residual disease technology in an effort to broaden testing access and boost adoption.
Myriad Genetics, GSK Collaborate on International Ovarian Cancer Testing Program
GSK will provide financial support for a program to expand access to Myriad's MyChoice tests for patients with high-grade serous ovarian cancer.
Labs, Doctors Still Grapple With Patient Recontact Despite Streamlined Variant Reclassification
Premium
Although leading labs have coalesced around the value of protocols for making sure updated variant calls get to patients, strategies still vary and practical challenges remain.
Qiagen, Myriad Genetics to Develop Sequencing-Based Homologous Recombination Deficiency Kit
Qiagen will develop and distribute a next-generation sequencing kit-based HRD test outside the US based on Myriad's MyChoice CDx biomarkers.
Oct 9, 2023